Dinkla S, Wessels K, Verdurmen WP, Tomelleri C, Cluitmans JC, Fransen J, et al
References: IQVIA LAAD pharmacy claims data, US Market Access Strategy Consulting analysis Eli Lilly Tightens Access to Diabetes Drug, Frustrating Some People with Obesity, STAT News New Demand in an Old Market Read part 2 of this blog series to learn how the launch of Mounjaro transformed the GLP-1 market and led to the emergence of a new type of patient access profile thats challenging todays traditional diabetes care paradigm
Rhonda Patrick explores multivitamins and brain aging, vitamin D, hidden nutrient deficiencies, and links between diet, hypertension, and
If you are looking to support weight management, consistency is more important than a high "one-off" dose
Your dose may need to go up during the first 412 weeks as your body adjusts